Ironwood Pharmaceuticals (IRWD +4.7%) trades up after Credit Suisse raises the shares to...

|About: Ironwood Pharmaceuticals, Inc. (IRWD)|By:, SA News Editor

Ironwood Pharmaceuticals (IRWD +4.7%) trades up after Credit Suisse raises the shares to Outperform and raised its price target to $24 from $15. The firm says IRWD is poised to see strong demand for its IBS drug Linzess, based on a survey of 100 physicians.